New Onset Refractory Status Epilepticus

Clinical trial pipeline · Data from ClinicalTrials.gov

See which New Onset Refractory Status Epilepticus trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 3

NCT07281027

COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

The goal of this clinical trial is to find out whether two existing medications-anakinra and tocilizumab-can effectively treat a rare and life-threatening brain…

United States438 participantsStarted 2026-03-01

Treatment: Anakinra, Tocilizumab